A detailed history of Naples Global Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Naples Global Advisors, LLC holds 54,478 shares of AZN stock, worth $3.58 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
54,478
Previous 53,778 1.3%
Holding current value
$3.58 Million
Previous $4.19 Million 1.19%
% of portfolio
0.4%
Previous 0.43%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$76.67 - $87.62 $53,669 - $61,334
700 Added 1.3%
54,478 $4.24 Million
Q2 2024

Jul 18, 2024

BUY
$66.81 - $80.83 $24,719 - $29,907
370 Added 0.69%
53,778 $4.19 Million
Q1 2024

Apr 29, 2024

BUY
$61.03 - $69.57 $292,333 - $333,240
4,790 Added 9.85%
53,408 $3.62 Million
Q4 2023

Jan 11, 2024

BUY
$61.89 - $69.28 $242,299 - $271,231
3,915 Added 8.76%
48,618 $3.27 Million
Q3 2023

Oct 16, 2023

BUY
$64.85 - $71.7 $120,296 - $133,003
1,855 Added 4.33%
44,703 $3.03 Million
Q2 2023

Jul 17, 2023

SELL
$69.91 - $75.81 $2,936 - $3,184
-42 Reduced 0.1%
42,848 $3.07 Million
Q1 2023

Apr 17, 2023

BUY
$63.15 - $71.6 $57,087 - $64,726
904 Added 2.15%
42,890 $2.98 Million
Q4 2022

Jan 20, 2023

BUY
$54.21 - $70.44 $50,144 - $65,157
925 Added 2.25%
41,986 $0
Q3 2022

Oct 20, 2022

BUY
$53.02 - $135.75 $13,255 - $33,937
250 Added 0.61%
41,061 $2.25 Million
Q2 2022

Aug 11, 2022

BUY
$59.26 - $71.14 $40,178 - $48,232
678 Added 1.69%
40,811 $2.7 Million
Q1 2022

Apr 28, 2022

BUY
$55.72 - $67.12 $33,432 - $40,272
600 Added 1.52%
40,133 $2.66 Million
Q4 2021

Feb 04, 2022

BUY
$54.02 - $63.83 $9,453 - $11,170
175 Added 0.44%
39,533 $2.3 Million
Q3 2021

Oct 25, 2021

BUY
$55.56 - $60.79 $22,224 - $24,316
400 Added 1.03%
39,358 $2.36 Million
Q2 2021

Aug 06, 2021

BUY
$48.42 - $60.18 $153,733 - $191,071
3,175 Added 8.87%
38,958 $2.33 Million
Q1 2021

May 10, 2021

SELL
$47.16 - $54.44 $3,065 - $3,538
-65 Reduced 0.18%
35,783 $1.78 Million
Q4 2020

Feb 08, 2021

BUY
$48.52 - $58.02 $27,899 - $33,361
575 Added 1.63%
35,848 $1.79 Million
Q3 2020

Oct 26, 2020

BUY
$53.07 - $61.1 $14,063 - $16,191
265 Added 0.76%
35,273 $1.93 Million
Q2 2020

Aug 04, 2020

BUY
$43.1 - $55.31 $103,440 - $132,744
2,400 Added 7.36%
35,008 $1.85 Million
Q1 2020

Apr 27, 2020

BUY
$37.79 - $51.33 $26,453 - $35,931
700 Added 2.19%
32,608 $1.46 Million
Q4 2019

Feb 05, 2020

SELL
$42.46 - $50.46 $3,184 - $3,784
-75 Reduced 0.23%
31,908 $1.59 Million
Q2 2019

Jul 10, 2019

BUY
$37.28 - $41.68 $33,552 - $37,512
900 Added 2.9%
31,983 $1.32 Million
Q1 2019

Apr 29, 2019

SELL
$35.49 - $43.02 $27,362 - $33,168
-771 Reduced 2.42%
31,083 $1.26 Million
Q4 2018

Feb 01, 2019

SELL
$36.86 - $41.49 $65,573 - $73,810
-1,779 Reduced 5.29%
31,854 $1.22 Million
Q3 2018

Nov 13, 2018

BUY
$34.76 - $39.72 $39,974 - $45,678
1,150 Added 3.54%
33,633 $1.33 Million
Q2 2018

Jul 23, 2018

BUY
$34.55 - $37.05 $72,555 - $77,805
2,100 Added 6.91%
32,483 $1.14 Million
Q1 2018

Apr 17, 2018

BUY
$32.97 - $36.63 $8,242 - $9,157
250 Added 0.83%
30,383 $1.06 Million
Q4 2017

Jan 19, 2018

BUY
$32.09 - $34.78 $56,221 - $60,934
1,752 Added 6.17%
30,133 $1.05 Million
Q3 2017

Oct 16, 2017

BUY
$28.96 - $34.0 $821,913 - $964,954
28,381
28,381 $962,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Naples Global Advisors, LLC Portfolio

Follow Naples Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Naples Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Naples Global Advisors, LLC with notifications on news.